Applied Monitoring raises £500k from Mercia Ventures and the North East Venture Fund to launch its wearable lactate monitor.
The funding was led by Mercia Ventures and the North East Venture Fund to help bring the non-invasive health sensor to market.
Applied Monitoring develops non-invasive sensor technology designed to continuously track blood lactate levels for athletes and healthcare settings. The Sunderland-based firm is preparing to launch its wearable devices following trials at Durham University.
Sunderland-based sensor developer Applied Monitoring has secured £500k in funding from the North East Venture Fund, managed by Mercia Ventures and supported by the European Regional Development Fund. The capital will support the commercial rollout of the company's wearable lactate monitor within the next twelve months.
Founded in 2018, the firm has created a non-invasive method for continuously measuring blood lactate to help athletes manage exertion. Following trials at Durham University, Applied Monitoring has contracted a European microchip producer to miniaturise the technology for armbands and smartwatches, with future applications planned for hospital sepsis and glucose monitoring.
From the founder
"A build-up of lactic acid causes muscles to seize up and athletes to suddenly ‘hit a wall’, but it’s hard for them to know when this will happen without measuring lactate levels. Fingerprick tests are uncomfortable, fiddly and not always accurate. Our device will overcome these problems and provide continuous monitoring, rather than a one-off measurement. This latest funding, together with our partnership with a major global chip manufacturer, will enable us to bring it to market."
Jon Dixon
Co-founder and CEO at Applied Monitoring
Use of funds
- 01Continue product development
- 02Accelerate go-to-market
Investors
Categories
About the company
Applied Monitoring
Applied Monitoring develops non-invasive sensor technology to track blood lactate levels.